Borns has successfully entered overseas markets，We have cooperated with Max Hospital (Max Healthcare), the largest listed medical group in India, to carry out a comprehensive cooperation including clinical trials, product registration and marketing integration. Max Hospital Group covers 520 cities including Delhi and Mumbai, as well as 145 countries and regions around the world, serving nearly 3 million patients every year, and is the world's general hospital.

Borns is collaborating with Max Hospital (Max Hospital Vaishali) Center for Minimally Invasive and Robotic Surgery to conduct a global, clinical multicenter study to verify the clinical application, physician training and market exploration of the Borns Surgical Robotic System.

The Max Hospital Minimally Invasive Surgery and Robotics Center Director, Dr. Vivek Bindal stated: "Borns system fully considers the clinical needs of the doctor, including rich surgical instrument selection and open modular mechanical arm design, according to the flexible configuration system, at the same time the high precision control and stability is impressive, lets us more easily complete the various types of difficult surgery".

CMO, Director of Clinical Medicine, Germany Gottingen University Professor Dr. Alexander Teichmann witnessed the success of the clinical trial, and said "I have been engaged in endoscopic surgery in Germany for more than 30 years, we are delighted to see the successful application of multiple departments, including gastrointestinal surgery, hepatobiliary surgery, spleen surgery, abdominal wall hernia repair operation embodies the excellent performance". Dr. Teichmann is confident in the international multi-center and multi-department clinical research, including India, China and the European Union!

Borns, COO, Mr Mark Goldin said: " as the starting point of the global multicenter clinical research, Max hospital and colleagues make us very excited, our surgical robot system recognized by the international medical experts, is a significant progress of medical without borders cooperation, but also for the future robot surgery standardization market application is of great significance.”

About the Borns Surgical Robotic System

The system exemplifies sub-millimeter ultra-fine control technology, achieving microbleeding in ultra-minimally invasive surgery, resulting in shortened recovery time for patients.

The proprietary open surgery platform is fully compatible with the existing energy surgery platform and medical imaging system in the operating room, and realizes the comprehensive automatic upgrade of minimally invasive abdominal surgery.

Fully support the 4K3D ICG (fluorescence) imaging system, which can accurately locate fine blood vessels, nerve and tumor tissue, fully meet the needs of all kinds of surgery, and improve the surgical accuracy and safety.

The full degree of freedom force feedback master operator system and simulation training system greatly enhance the reality of doctors' operation and shorten the learning curve.

At the same time, it has a full series of disposable 5mm surgical instruments and wrist surgical instruments, fully considering the needs of hospitals at all levels, doctors and patients at all levels, to achieve the balance between clinical application and product value.

Dr. William Levin (William Levine), CTO of Borns, said: " Technological innovation comes from real clinical needs, and many of our innovative surgical robot technologies were finally recognized by doctors and patients. This is a historic moment!”

Nature In 2020, the magazine reported on the Borns Medical Robot AI surgical system, specifically mentioning that the core control technology and open platform (energy platform and imaging system) make the surgical configuration flexible while ensuring accuracy and stability.

Borns Surgical Robotic System